Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-term, Multicenter, Single-arm, Open-label Extension of the SERENADE Study, to Assess the Safety and Efficacy of Macitentan in Subjects With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease

NCT03714815 is registered in ClinicalTrials.gov with Actelion as lead sponsor.

NCT NCT03714815
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03714815 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-term, Multicenter, Single-arm, Open-label Extension of the SERENADE Study, to Assess the Safety and Efficacy of Macitentan in Subjects With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease
Lead sponsor
Actelion
Phase
Phase 2
Overall status
Terminated
Start date
December 7, 2018
Completion date
October 12, 2021
Enrollment
91 (actual)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure with preserved ejection fraction and pulmonary vascular disease